Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Erzsébet, Csernák"'
Autor:
Erika Tóth, Zsófia Kürönya, Edina Soós, Tamás Pintér, Henriett Butz, Zsolt Horváth, Erzsébet Csernák, Vince Kornél Grolmusz, Judit Székely, Tamás Straussz, József Lövey, Levenete Jánvári, László Báthory-Fülöp, Péter Nagy, Csaba Polgár, Attila Patócs
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Recent developments in molecular genetic testing methods (e.g. next-generation sequencing [NGS]-panels) largely accelerated the process of finding the most appropriate targeted therapeutic intervention for cancer patients based on molecularly targeta
Externí odkaz:
https://doaj.org/article/2378294547c842d0a17ba88dade9265b
Autor:
Eszter Bencze, Krisztina Bogos, Andrea Kohánka, László Báthory-Fülöp, Veronika Sárosi, Erzsébet Csernák, Nóra Bittner, Zsombor Melegh, Erika Tóth
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
EGFR mutation in non-small cell lung cancer (NSCLC) offers a potential therapeutic target for tyrosine kinase inhibitor (TKI) therapy. The majority of these cases, however eventually develop therapy resistance, mainly by acquiring EGFR T790M mutation
Externí odkaz:
https://doaj.org/article/791ae1e67c614efcaf1a1b0756e5936c
Autor:
Simona Gurzu, Zoltán Szentirmay, Erzsébet Csernák, Genoveva Rigmanyi, Ioan Jung, Laura Banias, Zsolt Kovacs
Publikováno v:
World Journal of Clinical Oncology
BACKGROUND Nucleic acid isolation from formalin-fixed, paraffin-embedded tissue (FFPET) samples is a daily routine in molecular pathology laboratories, but extraction from FFPET is not always easily achieved. Choosing the right extraction technique i
Publikováno v:
Orvosi Hetilap. 159:1614-1623
Abstract: Genome-wide association studies (GWAS) using population-based designs have identified many genetic loci, at which common variants can influence the risk of developing the sporadic colon cancers. These are single nucleotide polymorphisms (SN
Publikováno v:
International Journal of Surgical Pathology. 26:382-387
A combination of ovarian tumors with the same histogenetic origin but different histologic subtype is relatively common, whereas a co-occurrence of tumors with different histogenetic origin is rare. We report a case of mixed ovarian tumor composed of
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 25:460-466
The implementation of targeted therapies revolutionized oncology. As the number of new oncogenic driver mutations, which provide molecular targets for prediction of effective and selective therapies, is increasing, the implementation of fast and reli
Publikováno v:
Orvosi hetilap. 159(40)
Genome-wide association studies (GWAS) using population-based designs have identified many genetic loci, at which common variants can influence the risk of developing the sporadic colon cancers. These are single nucleotide polymorphisms (SNPs) locate
Autor:
Muhammed Sohail, Paidamwoyo Gwiti, Jeremy P Braybrooke, David S Cundell, Zsombor Melegh, Shazia Aslam, Katalin Götzer, Erzsébet Csernák, Ildikó Vereczkey, Tim Clench
Publikováno v:
Histopathology. 71(5)
Low-grade serous neoplasms of the testis are rare neoplasms that show striking morphological similarities with the better-understood ovarian neoplasms. This study is to see if there are similar molecular abnormalities in these two tumours. The cell o
Publikováno v:
Pediatric Pathology & Molecular Medicine. 22:213-222
We have used semiquantitative comparative and real-time quantitative polymerase chain reactions (PCR) to detect n-myc gene-amplification in 20 frozen neuroblastoma biopsies and IMR 32 cell line to predict biological behavior of the tumors. Two primer
Autor:
Erika Tóth, Erzsébet Csernák, Zoltán Szentirmay, Zsófia Küronya, Judit Olasz, Ildikó Vereczkey
Publikováno v:
International journal of surgical pathology. 20(6)
Choriocarcinoma is a rare, highly malignant trophoblastic tumor with gestational or, rarely, germ cell origin. Primary extragenital localization is extremely rare. This report describes a choriocarcinoma case clinically mimicking a primary renal cell